The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
metabolic health because we have some drug trials and and mandilon randomizations now where they modulate HDL and it doesn't really seem to make a difference yeah um whereas if you modulate LDL so even at high HDL or low HDL in both stratifications lower LDL is almost always better for cardiovascular disease and Mortal
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.